ALK Fusion in an Adolescent with Acute Myeloid Leukemia: A Case Report and Review of the Literature

Activating mutations and fusions of the ALK oncogene have been identified as drivers in a number of malignancies. Crizotinib and subsequent ALK tyrosine kinase inhibitors have improved treatment outcomes for these patients. In this paper, we discuss the case of an adolescent patient with acute myelo...

Descripción completa

Detalles Bibliográficos
Autores principales: Shekar, Meghan, Llaurador Caraballo, Gabriela, Punia, Jyotinder N., Curry, Choladda V., Fisher, Kevin E., Redell, Michele S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377196/
https://www.ncbi.nlm.nih.gov/pubmed/37509482
http://dx.doi.org/10.3390/biomedicines11071842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377196/
https://www.ncbi.nlm.nih.gov/pubmed/37509482
http://dx.doi.org/10.3390/biomedicines11071842

Ejemplares similares